Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
560-01-003 ISMRM Abstract

Single breath-hold high-resolution quantitative susceptibility mapping of the liver using CAIPIRINHA-accelerated 3D EPI

Primary: Acquisition & Reconstruction - Quantitative Imaging: chest, abdomen, and pelvis
Secondary: Contrast Mechanisms - Susceptibility/QSM
560-01-003 · New Developments in QSM I · Wednesday, 13 May, 8:20 AM–9:15 AM · Digital Posters Row A
Keywords: Abbreviated/Rapid MRI Liver Quantitative Susceptibility Mapping (QSM)
Accepted
Sjoerd B Vos1, Hamed Moradi1,2, Jin Jin2,3, Leon A Adams4,5, Oyekoya T Ayonrinde5,6,7, Kieran R O'Brien 2,3, Paul M Parizel1,5,8
1Western Australia National Imaging Facility, The University of Western Australia, Perth, Australia
2Siemens Healthineers (ANZ), Bowen Hills, Australia
3Australian Institute for Bioengineering and Nanotechnology, Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia
4Department of Hepatology, Sir Charles Gairdner Hospital, Perth, Australia
5Medical School, The University of Western Australia, Perth, Australia
6Faculty of Health Sciences, Curtin University, Perth, Australia
7Department of Gastroenterology and Hepatology, Fiona Stanley Hospital, Perth, Australia
8Department of Radiology, Royal Perth Hospital, Perth, Australia
Presenting Author: Kieran R O'Brien

Synopsis

Motivation:
Goals:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Jafari, Hectors, Koehne de Gonzalez, et al. Integrated quantitative susceptibility and R2* mapping for evaluation of liver fibrosis: an ex vivo feasibility study. NMR in Biomed 2020;34(1):e4412.
2. Qu, Yang, Xing, et al. Magnetic Resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study. Quant Imaging Med Surg 2021;11(4):1170-83.
3. Bilgic, Costagli, Chan, et al. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. Magn Reson Med 2024;91(5):1834-62.
4. Tourell, Jin, Bachrata, et al. Three-dimensional EPI with shot-selective CAIPIRINHA for rapid high-resolution quantitative susceptibility mapping at 3T. Magn Reson Med 2024;92(3):997-1010.
5. Stewart, Robinson, O’Brien, et al. QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping. Magn Reson Med 2021;87(3):1289-1300.
6. Schneider, Benkert, Solomon, et al. Free-breathing fat and R2* quantification in the liver using a stack-of-stars multi-echo acquisition with respiratory-resolved model-based reconstruction. Magn Reson Med 2020;84(5):2592-605.
7. Schwenzer, Machann, Haap, et al. T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects – correlation with age, gender, and serum ferritin. Inv Radiol 2008;43(12):854-860.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/560-01-003